| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/06/2010 | US20100113326 Dimeric iap inhibitors |
| 05/06/2010 | US20100112634 Yeast strains autonomously producing steroids |
| 05/06/2010 | US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 05/06/2010 | US20100112082 Determining and Reducing Immunoresistance to a Botulinum Toxin Therapy Using Botulinum Toxin B Peptides |
| 05/06/2010 | US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100112011 Photodynamic therapy-generated mesothelioma vaccine |
| 05/06/2010 | US20100112008 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 05/06/2010 | US20100112003 Bifidobacterium in the treatment of inflammatory disease |
| 05/06/2010 | US20100112002 Modified Pathogens for Use as Vaccines |
| 05/06/2010 | US20100112000 Non-tumorigenic mdck cell line for propagating viruses |
| 05/06/2010 | US20100111996 Papaya Mosaic Virus-Based Vaccines for Influenza |
| 05/06/2010 | US20100111993 Recombinant vaccines and use thereof |
| 05/06/2010 | US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women |
| 05/06/2010 | US20100111989 Rsv f-protein and its use |
| 05/06/2010 | US20100111985 Vaccine compositions and methods of use |
| 05/06/2010 | US20100111982 Rheumatoid arthritis t cell vaccine |
| 05/06/2010 | US20100111981 Synthetic monodisperse hemozoin crystals preparation and uses thereof |
| 05/06/2010 | US20100111980 Binding partners of antibodies specific for dendritic cell antigens |
| 05/06/2010 | US20100111968 Methods for Mediating Fibrotic Response |
| 05/06/2010 | US20100111954 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/06/2010 | US20100111952 Treatment of autoimmune disorders |
| 05/06/2010 | US20100111939 Monoclonal antibody and use thereof |
| 05/06/2010 | US20100111934 Determining Immunoglobulins In Non-Blood Body Fluids Of Neonatal Ungulates |
| 05/06/2010 | US20100111927 Compositions Comprising Actinidia and Methods of Use Thereof |
| 05/06/2010 | US20100111916 Materials and Method of Modulating the Immune Response |
| 05/06/2010 | US20100111910 Treatment of excessive neovascularization |
| 05/06/2010 | US20100111902 Composition for transmucosal delivery of polypeptides |
| 05/06/2010 | US20100111866 Receptor and Antigen Targeted Prodrug |
| 05/06/2010 | US20100111853 Antibodies that bind to il-12 and methods of purifying the same |
| 05/06/2010 | CA2742049A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
| 05/06/2010 | CA2741664A1 Method for selective control of helper t cell function |
| 05/06/2010 | CA2741661A1 Novel amide derivative and use thereof as medicine |
| 05/06/2010 | CA2741434A1 Drug for treating infections |
| 05/06/2010 | CA2740058A1 An antidiabetic agent |
| 05/06/2010 | CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181710A1 Ligands for modulation of orphan receptor-gamma (NR1F3) activity |
| 05/05/2010 | EP2181120A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
| 05/05/2010 | EP1167366B1 Amine derivatives |
| 05/05/2010 | EP1115398B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/05/2010 | EP0703783B1 Methods of making immunogenic hla-a2.1 binding peptides |
| 05/05/2010 | CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/05/2010 | CN1964730B Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same |
| 05/05/2010 | CN1919270B Composition, exract, and pharmaceutical use thereof |
| 05/05/2010 | CN1878767B Azole-based kinase inhibitors |
| 05/05/2010 | CN1832925B New P2X7 receptor avtagonists and their use |
| 05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
| 05/05/2010 | CN1646151B Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
| 05/05/2010 | CN1416341B Stable emulsion compositions |
| 05/05/2010 | CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof |
| 05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
| 05/05/2010 | CN101700290A Pharmaceutical composition for preventing and treating warm-heat diseases of livestock and poultry and preparation method thereof |
| 05/05/2010 | CN101700280A Traditional Chinese medicine for treating allergic rhinitis |
| 05/05/2010 | CN101700266A Saussurea involucrate nano particles and preparation method and application thereof |
| 05/05/2010 | CN101700255A Compound fermentation glossy ganoderma capsule and preparation method thereof |
| 05/05/2010 | CN101700239A Combined capsule filled with glycyrrhizin solid preparation and glycine solid preparation |
| 05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709473 5-[2-(6-tert-Butyl-3-oxo-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8-ylamino)-ethoxy]-nicotinic acid methyl ester; inhibitors of glycogen synthase kinase 3 (GSK-3); diabetes, dementia, Alzheimer's Disease, bipolar disorder, stroke, schizophrenia, depression, hair loss, cancer |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 05/04/2010 | US7709451 Method and composition for treating immune complex associated disorders |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2427385C Nutritional composition for an immune condition |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 05/04/2010 | CA2320467C Cycloalkene derivatives, their production and use |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA2172398C Methods and products for controlling immune responses in mammals |
| 05/04/2010 | CA1341604C Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047310A1 Tumor antigen peptide and use thereof |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047117A1 Novel monoclonal antibody and use thereof |
| 04/29/2010 | WO2010046835A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | WO2010046791A1 Phosphodiestarase inhibitors |
| 04/29/2010 | WO2010046783A2 A1 moiety of cholera toxin a subunit as an adjuvant for mucosal and systemic vaccines |
| 04/29/2010 | WO2010046377A2 Immunoactivating conjugates comprising nanoparticles coated with peptides |
| 04/29/2010 | WO2010046338A1 Composition for targeting dendritic cells |
| 04/29/2010 | WO2010045862A1 Drug for treating leucoderma |
| 04/29/2010 | WO2010045674A1 Methods for inducing programmed cell death |